Search research articles
Contact Us
Filters
Showing results (1-10 of 116) with videos related to
Page
of 12
Sort By:
Frontiers in Endocrinology
|
June 7, 2021
Apolipoprotein M-A Marker or an Active Player in Type II Diabetes?
Christina Christoffersen
International Journal of Molecular Sciences
|
July 28, 2017
A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation
Stefan Hajny, Christina Christoffersen
Current Opinion in Lipidology
|
April 23, 2019
Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology
Line S Bisgaard, Christina Christoffersen
Current Opinion in Lipidology
|
May 9, 2013
Apolipoprotein M: bridging HDL and endothelial function
Christina Christoffersen, Lars Bo Nielsen
Atherosclerosis
|
September 5, 2021
Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system
Ingrid Yao Mattisson, Christina Christoffersen
Critical Care (London, England)
|
May 17, 2012
Apolipoprotein M--a new biomarker in sepsis
Christina Christoffersen, Lars Bo Nielsen
Frontiers in Medicine
|
November 1, 2021
The apoM/S1P Complex-A Mediator in Kidney Biology and Disease?
Line S Bisgaard, Christina Christoffersen
Ugeskrift for Laeger
|
March 17, 2009
[Heparin-induced thrombocytopenia]
Christina Christoffersen, Stefan Lethagen, Jens Peter Gøtze
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
May 29, 2021
Increased plasma apoM levels impair triglyceride turnover in mice
Stefan Hajny, Anna Borup, Sara Elsøe, et al.
Trends in Endocrinology and Metabolism: TEM
|
February 10, 2009
ApoM: gene regulation and effects on HDL metabolism
Lars B Nielsen, Christina Christoffersen, Josefin Ahnström, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 116) with videos related to
Sort By:
Page
of 12
Frontiers in Endocrinology
|
June 7, 2021
Apolipoprotein M-A Marker or an Active Player in Type II Diabetes?
Christina Christoffersen
International Journal of Molecular Sciences
|
July 28, 2017
A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation
Stefan Hajny, Christina Christoffersen
Current Opinion in Lipidology
|
April 23, 2019
Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology
Line S Bisgaard, Christina Christoffersen
Current Opinion in Lipidology
|
May 9, 2013
Apolipoprotein M: bridging HDL and endothelial function
Christina Christoffersen, Lars Bo Nielsen
Atherosclerosis
|
September 5, 2021
Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system
Ingrid Yao Mattisson, Christina Christoffersen
Critical Care (London, England)
|
May 17, 2012
Apolipoprotein M--a new biomarker in sepsis
Christina Christoffersen, Lars Bo Nielsen
Frontiers in Medicine
|
November 1, 2021
The apoM/S1P Complex-A Mediator in Kidney Biology and Disease?
Line S Bisgaard, Christina Christoffersen
Ugeskrift for Laeger
|
March 17, 2009
[Heparin-induced thrombocytopenia]
Christina Christoffersen, Stefan Lethagen, Jens Peter Gøtze
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
May 29, 2021
Increased plasma apoM levels impair triglyceride turnover in mice
Stefan Hajny, Anna Borup, Sara Elsøe, et al.
Trends in Endocrinology and Metabolism: TEM
|
February 10, 2009
ApoM: gene regulation and effects on HDL metabolism
Lars B Nielsen, Christina Christoffersen, Josefin Ahnström, et al.
Page
of 12